Simulating Patient Reactions
Compliance Materials
refine messaging and improve outcomes
healthcare compliance materials
A global pharmaceutical company was preparing to launch a new treatment for a chronic condition across multiple European markets. As part of the regulatory process, they were required to provide clear, patient-facing compliance materials—brochures, digital leaflets, and consent forms—that explained dosage instructions, side effects, and follow-up requirements in layperson’s terms.
However, the client faced a dilemma common in early-stage communication testing:
The company needed rapid, evidence-based feedback to refine messaging before launch—without breaching compliance regulations or waiting weeks for traditional recruitment and fieldwork.
That’s where DataDiggers, powered by its synthetic research suite—Syntheo and Modeliq—stepped in.
To overcome regulatory and timeline constraints, DataDiggers proposed a hybrid synthetic simulation approach that leveraged:
Using Syntheo, we developed highly detailed synthetic personas representing the client’s target patient profiles:
Each persona mirrored the behavioral patterns, decision-making tendencies, and comprehension barriers commonly seen in actual patients—without any exposure to real respondents or PHI (Protected Health Information).
Modeliq was then used to run simulation tests on the early versions of the compliance materials. We modeled:
Three material variants were tested, each with slightly different wording and layout.
Using synthetic data models, the client was able to:
✅ Identify the most effective wording and visual combination before real-world testing
✅ Refine the tone of voice for more empathetic, comprehension-friendly communication
✅ Save weeks of traditional testing timelines
✅ Avoid any compliance breach by keeping all simulations in a synthetic sandbox
This simulation was only possible thanks to DataDiggers' layered technology stack:
Critically, the entire project followed GDPR and ISO 20252:2019 compliance standards, reinforcing both ethical research practices and credible outcomes.
The pharmaceutical company finalized its compliance materials using Variant B—confident in its projected performance across key patient groups. The simulation also empowered their regulatory affairs team to present evidence-backed rationale for their communication strategy to health authorities.
“DataDiggers gave us the clarity we needed when it mattered most—without breaking timelines or rules. Their synthetic approach turned a legal and logistical hurdle into a strategic advantage.”
— VP, Global Patient Communications, Pharmaceutical Client
In today’s complex regulatory and ethical environment—especially in healthcare—synthetic simulations are not a luxury, but a necessity. When traditional research isn’t possible, DataDiggers enables decision-makers to test early, iterate fast, and stay compliant with zero compromise on insight quality.
Through Syntheo, Modeliq, and Correlix, we deliver simulation-grade precision—from synthetic patients to real-world decisions.